Parameters of Nonspecific and Specific Immune Resistance in Episodic Remittent Paranoid Schizophrenia Compared with Unfavorably Current Form of Episodic Paranoid Schizophrenia

Irina I. Mikhailova, PhD¹*; Vera A. Orlova, PhD, ScD¹; Vitaly L. Minutko², PhD, ScD; Irina N. Malisheva³; Boris G. Gorodkov¹; Nina A. Eliseeva, PhD¹

¹The Mental Health Research Center of RAMS; ²“Mental Health” Clinic; ³ Modern Medical Technologies Clinic “ArchiMed”; Moscow, Russian Federation.

*Corresponding author: Irina I. Mikhailova, PhD. The Mental Health Research Center of RAMS; Moscow, Russian Federation E-mail: iim@bk.ru

Published: December 25, 2013 

Abstract: 

Although the immune component of the pathogenesis of schizophrenia is well documented and recognized, the characteristics of the relationship between nonspecific and specific immune resistance and their correlation with the form and course of the disease continue to remain practically unexplored.

The aim of this study was to investigate the systemic relationships present between the multiple parameters of the immune system (cellular, humoral and phagocytic defenses, the serum levels of the antibodies to herpes simplex virus type 1, herpes simplex virus type 2, cytomegalovirus  and  Epstein-Barr virus) in episodic remittent paranoid schizophrenia (ERPS) compared with unfavorably current form of episodic paranoid schizophrenia with progressive or stable deficit (EPSPSD).

Material and Methods: The study included 32 patients with ERPS (main group) and 30 patients with EPSPSD (control group). We determined the leukocyte content, the lymphocyte subpopulations and the leukocyte phagocytosis in PHAGOTEST with fluorescein (FITC)-labeled opsonized bacteria and calculated the Phagocytic Index (PhI), the circulating immune complexes (CIC) level by spectrophotometry. The antibodies against the herpesviruses (HSV-1, HSV-2, CMV, EBV) were determined using the ELISA test. Total Serum immunoglobulins, IgG, IgM, and IgA, were determined by immunoturbidimetry.

Results: In the main group, a combination of immune responses to the viruses studied was observed, while in the control group, an immune response to herpes simplex virus type 1(HSV-1) -  herpes simplex virus type 2 (HSV-2) - cytomegalovirus  (CMV) association was found, as well as an immune response separately to Epstein-Barr virus (EBV). In both groups, the cellular immune deficit was noted to be more pronounced in the control group.

Conclusion: These results demonstrate a definite link between herpes infection and the immune resistance parameters of patients with the episodic paranoid schizophrenia. The results confirm the infectious theory of the diseases.

Keywords: 
schizophrenia; immune system; herpesviruses; HSV-1; HSV-2; CMV; EBV.
References: 

1. Lobachyova OA. Clinical and immunological patterns of adaptation in patients with schizophrenia. Abstract of ScD Thesis. Tomsk, 2011. [Abstract in Russian].

2. Nazarov DE The immune system in various phases of HBV, HCV, and HDV infections in patients with schizophrenia. Abstract of PhD Thesis. Kirov, 2005. [Abstract in Russian].

3. Vasil'eva EF, Kushner SG, Abramova LI, Kaleda VG,  Tsutsul’kovskaia MYu. The changes of the function of natural killer lymphocytes in schizophrenia. Zh Nevrol Psikhiatr Im S S Korsakova  2002;102(8):30-6. [Article in Russian].

4. Vasil'eva EF, Kolyaskina GI, Brusov OS, Faktor MI, Kaleda VG, Barkhatova NA, et al. The effect of serotonin on the cytotoxic activity of natural killer lymphocytes in patients with first-episode endogenous psychosis. Zh Nevrol Psikhiatr Im S S Korsakova  2011;111(4):61-6. [Article in Russian].

5. Muller N, Riedel M, Gruber R, Ackenheil M, Schwarz MJ. The immune system and schizophrenia. An integrative view. Ann NY Acad Sci 2000; 917:456 – 67

6. Mailyan KR, Boyadzhyan AS, Sogoyan AF, Sim RB, Manukian LA. Concentration and protein composition of circulating immune complexes in the blood of patients  with schizophrenia and subjects with positive familial history of disease. Zh Nevrol Psikhiatr Im S S Korsakova  2005;105(4):55-60. [Article in Russian].

7. Zozulya SA, Siryachenko TM, Kaleda VG, Dupin AM, Omelchenko MA, Otman I., Klushnik TP. The state of the immune system in endogenous mental diseases with pronounced affective disorders. Zh Nevrol Psikhiatr Im S S Korsakova  2011;111(12):63-7. [Article in Russian].

8. Sherbakova IV, Siryachenko TM, Sarmanova ZV,  Kaleda VG,  Barkhatova AN,  Lideman RR,  Klushnik TP.  Some indices of congenital and acquired immunity in patients with endogenous diseases of schizophrenic spectrum disorders.  Zh Nevrol Psikhiatr Im S S Korsakova  2005;105(5):47-51. [Article in Russian].

9.  Orlova VA, Mikhailova II, Minutko VL, Poletaev AB, Simonova AV, Eliseeva NA, et al. Abnormalities in the content of serum autoantibodies to the antigens of nervous tissue in patients with schizophrenia. In: «ZPRÁVY VĚDECKÉ IDEJE - 2013», Praha:Publishing House «Education and Science»; 2013:29 -33.

10.  Poletaev AB.  Physiologic Autoimmunity and Preventive Medicine - Bentham Science Publishers, 2013.

11. Marshall T. Microbe-human meta-genome as the key to prevention and predictions of chronic human diseases. The 3rd Moscow International scientific-practical conference "Immune-physiology. Autoimmunity in norm and disease, problems of preventive-predictive medicine. " Мoscow; 2012:193–196. [Article in Russian].

12. Vetlugina TP, Nevidimova TI, Nikitin VB Lobachyova OA, Bohan NA, VY Semke. Pathogenetic substantiation of immunecorrection technology in mental disorders and diseases of addiction. Siberian Gerald of Psychiatry and Addiction Psychiatry 2013; 1(76): 7-12. [Article in Russian].

13.  Brusov OS, Kaleda VG, GI Kolyaskina, Lavrov VF et al. Cytomegalovirus infection as a factor of resistance to treatment with neuroleptics in adolescence patients with first-episode of endogenous psychosis. Psychiatry 2007; 4:62-71. [Article in Russian].

14.  Brusov OS, Kolyaskina GI, Sekirina TP, SG Kushner, Vasilyeva EF, Kaleda VG.  The use of canonical correlation analysis for the evaluation of correlation strength  between clinical and biological parameters. Zh Nevrol Psikhiatr Im S S Korsakova  2010;110(1):11-9. [Article in Russian].

15.  Oyfa AI. Brain and virus (genetic hypothesis of the origin of mental illness). Мoscow, 1999. [Book in Russian].

16.  Orlova VA, Mikhailova II. The role of perinatal insalubrity in the manifestation of psychiatric symptoms in patients with schizophrenia. In Sat "Actual achievements of European science" in 2013. http://www.rusnauka.com/18_ADEN_2013/Medecine/7_141996.doc.htm

17. Crow T.J. The virogene Hypothesis of psychosis. Current Status.  In: Kurstak E, editor. Psychiatry and Biological Factors. New York: Plenum; 1991:.9-21.

18. Orlova VA, Serikova TM,  Chernischuk EN, Eliseeva NA, Kononenko IN. The problem of neurodegeneration in schizophrenia. Social and Clinical Psychiatry  2010; 2:67 -79. [Article in Russian].

19.  Krause D, Matz J, Weidinger E, Wagner J, Wildenauer A, Obermeier M, et al. The association of infectious agents and schizophrenia. World J Biol Psychiatry. 2010; 11(5):739-43.

20.  Mikhailova II, Orlova VA, Minutko VL Malysheva IN,  Panina AV,  Tokarev AS. Correlation between clinical symptoms and the level of serum antibodies to herpes group viruses in different course of paroxysmal schizophrenia  Natural and engineering sciences 2013; 3:128-32. [Article in Russian].

21.  Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, et al.  Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study. Ethiop Med J 2011;49 (3):211-20.

22.  Prasad KM, Eack SM, Goradia D, Pancholi KM, Keshavan MS, Yolken RH, et al. Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. Am J Psychiatry 2011;168(8):822-30.

23.  Yolken RH, Torrey EF, Lieberman JA, Yang S, Dickerson FB. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr Res 2011;128(1-3):61-5.

24.  Wang H, Yolken RH, Hoekstra PJ, Burger H, Klein HC. Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: The TRAILS study. Schizophr Res 2011;129(1):47-51.

25.  Kolyaskina GI, Brusov OS, TP Sekirin. The immune system in juvenile schizophrenia at the time of the first manifestation. Siberian Gerald of Psychiatry and Addiction Psychiatry 2008; 31(48):22-6. [Article in Russian].

26.  Kutko II, VM Frolov, Račkauskas . Effectiveness of cicloferon in patients with paranoid schizophrenia with therapeutic resistance and its effect on interferon status. http://elibrary.ru/item.asp?id=16333861 [Article in Russian]

27. Dickerson FB, Boronow JJ, Stallings CR, Origoni AE, Yolken RH.  Reduction of symptoms by valacyclovir in cytomegalovirus-seropositive individuals with schizophrenia. Am J Psychiatry 2003;160(12):2234-6.

28.  Dickerson FB, Stallings CR, Boronow JJ, Origoni AE, Sullens A, Yolken RH.  Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirus. Schizophr Res 2009; 107(2-3):147-9.

29. Gavrisheva NA, TV Antonova. Infectious process. Clinical and pathophysiological aspects. St. Petersburg: ELBI-SPb; 2006. [Book in Russian].

30. Alimbarova LM, Garayev MM. Laboratory methods in diagnosis of herpes infections.  In:  Lvov DK, Barinskiy IF, Garaeva MM,  Alimbarova LM, editors.   Actual problems herpesvirus infections. Moscow; 2004:8-25. [Book in Russian].

31.  Kudin AP. This "harmless" Epstein - Barr virus infection. Part 1. Characteristics of the pathogen. Immune response to the virus. "Medical News"  2006; 7:14-22. [Article in Russian].

32. Zheleznikova GF, Vasyakin LI, Monakhova NE, Pavlenko MA, Novozhilova EV, Popova NA, et al.  Apoptosis and the immune response in children with acute infectious mononucleosis. http://nature.web.ru/db/msg.html?mid=1164758&uri=index.html

33. Yushchuk ND, Stepanchenko AV Dekonenko EP. Nervous system lesions in herpetic infections.  Moscow:  "Profile"; 2005. [Book in Russian].

34. Malashenkova IK Didkovskiy NA, Sarsaniya ZH.SH. et al. Clinical forms of chronic Epstein - Barr virus infection: diagnosis and treatment. "News of medicine and pharmacy" 13 (219) 2007 / Handbook for specialist. [Article in Russian].

35.Yolken RH, Bachmann S, Ruslanova L, Lillehoj E., Ford G., Torrey E.F., et al. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia.  Clin Infect Dis 2001; 32(5): 842-4.

The fully formatted PDF version is available.

Download Article

Int J Biomed. 2013; 3(4):251-257. © 2013 International Medical Research and Development Corporation. All rights reserved.